Your session is about to expire
← Back to Search
Treatment for Ulcerative Colitis (CIDsCaNN Trial)
Summary
The CIDsCaNN Network is being established with the major goals of identifying why IBD develops so commonly in children and adolescents living in Canada, and of determining the best treatment strategies for different types of IBD. Focusing on a prospective, inception cohort of Canadian children of widely varied racial origins provides a unique opportunity to explore environmental risk factors early in life and close in time to disease onset, their influence on the host microbiome, and in the context of genetic susceptibility. In keeping with current treatment targets, assessed outcomes will include not only symptom resolution and growth, but also intestinal healing. We aim to identify best practice and to institute processes for continual improvement in care nationally.
- Ulcerative Colitis
- Crohn's Disease
- Inflammatory Bowel Disease
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Find a Location
Who is running the clinical trial?
Share this study with friends
Copy Link
Messenger